TITLE

COMPANY SPOTLIGHT - Merck KGaA

PUB. DATE
January 2007
SOURCE
PharmaWatch: Monthly Review;Jan2007, Vol. 6 Issue 1, p41
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article reports on a joint venture between Merck KGaA and Chi-Med, both a pharmaceutical company, in developing treatments for cancer with traditional Chinese medicine. The two companies have agreed to develop small molecule anti-cancer drugs using 10,000 natural substances from Chi-Med to help manufacture the products. Moreover, Chi-Med believes that traditional Chinese medicine is a major, under-exploited reservoir for the development of novel drugs for the global pharmaceutical market.
ACCESSION #
24004021

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics